glp 1 ai New AI-based research reveals GLP-1 side effects missed in clinical trials Machine learning designs new GCGR/GLP-1R

Gastrointestinal side effects compound the problem Nausea affects 44% of semaglutide users and 28% of tirzepatide users in clinical trials

Zhong, H

I explore all this in a feature story published today, which marks the kick off of a new series from The Globe and Mail called Skinny Inc, about the big business of weight-loss drugs: Also published today is a companion piece from my colleague Kelly Grant who digs deeper into the research and patient experience of these drugs: We have more coming in the series over the coming weeks, including stories on influencers, insurance coverage, the effect on the food industry and more

Patients should ask which of the four pharmacies will fill their specific prescription before ordering